DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
US FDA.
FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. 2013.
Accessed August 8, 2014. Available at
http://www.fda.gov/Drugs/DrugSafety/ucm369580.htm
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.